以色列 -
希伯来文 -
Ministry of Health
blood banking, hospital & lab products
טבע מדיקל (שיווק) בע"מ - אחות - disposable devices used in the prevention of accidental needle stick injuries
以色列 -
希伯来文 -
Ministry of Health
sakura tissue-tek products (system and accessories) for histopathology lab
פריגו ישראל סוכנויות בע"מ - אחר - ציוד עזר להכנת דגימות היסטולוגיות לשם אבחון
以色列 -
希伯来文 -
Ministry of Health
medical equip. for fertility&ivf lab.
זוטל בע"מ - מומחה - ציוד וראגנטים לשימוש במעבדות פוריות והפרייה חוץ גופית
以色列 -
希伯来文 -
Ministry of Health
ריתמונורם 150 מג
abbott medical laboratories ltd, israel - propafenone hydrochloride - טבליות מצופות פילם - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
以色列 -
希伯来文 -
Ministry of Health
ריתמקס 150 מג
abbott medical laboratories ltd, israel - propafenone hydrochloride - טבליות מצופות פילם - propafenone hydrochloride 150 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
以色列 -
希伯来文 -
Ministry of Health
ריתמקס 300 מג
abbott medical laboratories ltd, israel - propafenone hydrochloride - טבליות מצופות פילם - propafenone hydrochloride 300 mg - antiarrhythmics, class ic - prophylaxis and treatment of ventricular arrhythmias. prophylaxis and treatment of atrial fibrillation and flutter. prophylaxis and treatment of paroxysmal supraventricular tachycardia (psvt) associated with disabling symptoms.
以色列 -
希伯来文 -
Ministry of Health
uniter-transport swabs+medium
"דה גרוט מדיקל בע""מ" - אחות - בדיקת משטחי גרון
以色列 -
希伯来文 -
Ministry of Health
גליבק ® 100 מ"ג
novartis pharma services ag - imatinib as mesylate 100 mg - film coated tablets - imatinib - glivec is indicated for the treatment of adult patients and children 3 years of age and above with ph+ chronic myeloid leukaemia (ph+ -cml) in chronic phase accelerated phase or blast crisis. glivec is also indicated for the treatment of adult patients with kit (cd117) positive unresectable and/or metastatic malignant gastrointestinal stromal tumours (gist). glivec is also indicated for the treament of : adult patients with newly diagnosed philadelphia chromosome positive acute lymphoblastic leukemia (ph+ all) integrated with chemotherapy. adult patients with relapsed or refractory ph + all as monotherapy. adult patients with unresectable dermatofibrosarcoma protuberans (dfsp) and adult patients with recurrent and/or metastatic dfsp who are not eligible for surgery. adult patients with myelodyspiastic/myeloproliferative diseases (mds/mpd) associated with pdgfr ( platelet - derived growth factor receptor ) gene re- arrangements. adult patients with hypereosinophilic syndrome (hes) and/or chronic eosinophilic l